Published in Eur J Vasc Endovasc Surg on November 23, 2010
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg (2015) 4.18
Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg (2011) 2.69
A novel sec-independent periplasmic protein translocation pathway in Escherichia coli. EMBO J (1998) 2.57
Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. J Clin Endocrinol Metab (1996) 1.96
Nitrate reductase of Escherichia coli: completion of the nucleotide sequence of the nar operon and reassessment of the role of the alpha and beta subunits in iron binding and electron transfer. Mol Gen Genet (1989) 1.90
Isolation and characterization of the nikR gene encoding a nickel-responsive regulator in Escherichia coli. J Bacteriol (1999) 1.88
Tellurite reductase activity of nitrate reductase is responsible for the basal resistance of Escherichia coli to tellurite. Microbiology (1997) 1.87
TMAO anaerobic respiration in Escherichia coli: involvement of the tor operon. Mol Microbiol (1994) 1.86
Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial. Eur J Vasc Endovasc Surg (2010) 1.83
Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest (1992) 1.66
A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation. J Biol Chem (1999) 1.60
Tracheobronchial aspiration of foreign bodies: current indications for emergency plain chest radiography. Radiol Med (2006) 1.60
Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol (2002) 1.51
p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol (1996) 1.51
Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy (2011) 1.50
A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol (2001) 1.47
Quality of life in patients with small abdominal aortic aneurysm: the effect of early endovascular repair versus surveillance in the CAESAR trial. Eur J Vasc Endovasc Surg (2010) 1.46
A randomized study on eversion versus standard carotid endarterectomy: study design and preliminary results: the Everest Trial. J Vasc Surg (1998) 1.46
Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis (1992) 1.44
Retracted Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit. Br J Pharmacol (2012) 1.42
Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration. J Endocrinol Invest (1999) 1.40
Proposed nomenclature for the genes involved in molybdenum metabolism in Escherichia coli and Salmonella typhimurium. Mol Microbiol (1992) 1.40
No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg (2012) 1.39
Molecular genetic analysis of the moa operon of Escherichia coli K-12 required for molybdenum cofactor biosynthesis. Mol Microbiol (1993) 1.35
Involvement of the narJ and mob gene products in distinct steps in the biosynthesis of the molybdoenzyme nitrate reductase in Escherichia coli. Mol Microbiol (1996) 1.34
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31
TorD, a cytoplasmic chaperone that interacts with the unfolded trimethylamine N-oxide reductase enzyme (TorA) in Escherichia coli. J Biol Chem (1998) 1.30
Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J Mol Biol (1998) 1.26
Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol (2009) 1.25
Surgical care in octogenarians. Br J Surg (1996) 1.22
Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study. Vaccine (1990) 1.22
Long-term results of iliac aneurysm repair with iliac branched endograft: a 5-year experience on 100 consecutive cases. Eur J Vasc Endovasc Surg (2012) 1.15
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures. Collaborators of the EVEREST study group. Eversion versus standard carotid endartectomy. Eur J Vasc Endovasc Surg (1999) 1.15
Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene (2009) 1.15
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J Med Virol (1997) 1.14
NarJ is a specific chaperone required for molybdenum cofactor assembly in nitrate reductase A of Escherichia coli. Mol Microbiol (1998) 1.14
EPR and redox characterization of iron-sulfur centers in nitrate reductases A and Z from Escherichia coli. Evidence for a high-potential and a low-potential class and their relevance in the electron-transfer mechanism. Eur J Biochem (1992) 1.11
Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11
Expression and characterization of the Escherichia coli fdo locus and a possible physiological role for aerobic formate dehydrogenase. J Bacteriol (1995) 1.11
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis (2000) 1.09
Endoleak after endovascular aortic repair: classification, diagnosis and management following endovascular thoracic and abdominal aortic repair. J Cardiovasc Surg (Torino) (2010) 1.09
Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev (2000) 1.08
Correlation between serological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol (1994) 1.08
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol (1992) 1.08
The inducible trimethylamine N-oxide reductase of Escherichia coli K12: its localization and inducers. Biochim Biophys Acta (1989) 1.07
The inducible trimethylamine-N-oxide reductase of Escherichia coli K12: biochemical and immunological studies. Biochim Biophys Acta (1988) 1.07
Evidence of deterministic components in the apparent randomness of GRBs: clues of a chaotic dynamic. Sci Rep (2011) 1.06
Identification and expression of the Escherichia coli fdhD and fdhE genes, which are involved in the formation of respiratory formate dehydrogenase. J Bacteriol (1990) 1.06
Dosage of Tn916 circular intermediates in Enterococcus faecalis. Plasmid (1995) 1.06
Ischemia and infarction of the small bowel and colon: spectrum of imaging findings. Abdom Imaging (2006) 1.06
Part two: against the motion. Measuring intra-sac pressure measurements is of no benefit to the patient. Eur J Vasc Endovasc Surg (2011) 1.05
Presence in the 'silent' terminus region of the Escherichia coli K12 chromosome of cryptic gene(s) encoding a new nitrate reductase. Mol Microbiol (1987) 1.04
Formation of active heterologous nitrate reductases between nitrate reductases A and Z of Escherichia coli. Mol Microbiol (1992) 1.04
Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Cancer Res (1988) 1.04
Biochemical and immunological evidence for a second nitrate reductase in Escherichia coli K12. Eur J Biochem (1987) 1.04
The coordination and function of the redox centres of the membrane-bound nitrate reductases. Cell Mol Life Sci (2001) 1.04
Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. J Clin Virol (2002) 1.03
Involvement of the narJ or narW gene product in the formation of active nitrate reductase in Escherichia coli. Mol Microbiol (1992) 1.03
Purification and further characterization of the second nitrate reductase of Escherichia coli K12. Eur J Biochem (1990) 1.03
Chapter IV: Treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg (2011) 1.03
Mutants of Escherichia coli specifically deficient in respiratory formate dehydrogenase activity. J Gen Microbiol (1988) 1.01
Membrane reconstitution in chl-r mutants of Escherichia coli K 12. VIII. Purification and properties of the FA factor, the product of the chl B gene. Biochim Biophys Acta (1975) 1.01
Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer (1993) 1.01
Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma. Am J Physiol Lung Cell Mol Physiol (2000) 1.01
Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy (2012) 1.01
[Behavior of blood gastrin in humans after intravenous administration of cortisol]. Boll Soc Ital Biol Sper (1974) 1.00
Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients. Hum Genet (1990) 0.99
Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization. Infect Immun (2001) 0.99
Ventricular fibrillation caused by electrocoagulation during thoracic surgery. Acta Anaesthesiol Scand (2010) 0.98
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives. J Infect Dis (1992) 0.98
Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol (1999) 0.97
Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration (1993) 0.97
Identification in various chlorate-resistant mutants of a protein involved in the activation of nitrate reductase in the soluble fraction of a chlA mutant of Escherichia coli K-12. Biochim Biophys Acta (1985) 0.97
Crystal structure of oxidized trimethylamine N-oxide reductase from Shewanella massilia at 2.5 A resolution. J Mol Biol (1998) 0.97
A common pathway for the activation of several molybdoenzymes in Escherichia coli K12. Biochim Biophys Acta (1984) 0.97
Precursor forms of the subunits of nitrate reductase in chlA and chlB mutants of Escherichia coli K12. Eur J Biochem (1980) 0.97
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res (1986) 0.96
[A case of gossypiboma of the knee. Its computed tomographic diagnosis]. Radiol Med (2000) 0.96
3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy (2006) 0.96
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial. J Vasc Surg (2000) 0.96
Current results of total endovascular repair of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Torino) (2014) 0.96